Bioassay Development for Bispecific Antibodies—Challenges and Opportunities

Antibody therapeutics are expanding with promising clinical outcomes, and diverse formats of antibodies are further developed and available for patients of the most challenging disease areas. Bispecific antibodies (BsAbs) have several significant advantages over monospecific antibodies by engaging t...

Descripción completa

Detalles Bibliográficos
Autores principales: Register, Ames C., Tarighat, Somayeh S., Lee, Ho Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160952/
https://www.ncbi.nlm.nih.gov/pubmed/34069573
http://dx.doi.org/10.3390/ijms22105350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160952/
https://www.ncbi.nlm.nih.gov/pubmed/34069573
http://dx.doi.org/10.3390/ijms22105350

Ejemplares similares